Study Stopped
It was not possible to acquire the medical device
An Integrated Intervention of Computerized Cognitive Training and Physical Exercise in Virtual Reality for People With Alzheimer's Disease (JDome)
JDome
1 other identifier
interventional
N/A
1 country
1
Brief Summary
JDOME is a randomized controlled trial to test the effectiveness of a computerized cognitive training with the Brainer web platform and aerobic training with the JDOME system vs. a computerized cognitive training with the Brainer web platform and aerobic training with a standard exercise bike in subjects with Alzheimer's Disease at early stage. The JDome BikeAround is a tool that take people with dementia on a virtual bicycle tour along the paths of memories. It combines an exercise bike, a dome-shaped projector and Google Street View technology.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Jun 2022
Shorter than P25 for not_applicable alzheimer-disease
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 30, 2022
CompletedFirst Posted
Study publicly available on registry
June 2, 2022
CompletedStudy Start
First participant enrolled
June 27, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 26, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
June 26, 2023
CompletedOctober 26, 2023
October 1, 2023
12 months
May 30, 2022
October 24, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
change in cognitive impairment
Mini-Mental State Examination was designed as a clinical method for grading cognitive impairment. The score ranges from 0 to 30: scores ≥ 24 indicate normality, between 18-23 indicate mild cognitive impairment, between 11-17 moderate cognitive deficits, scores ≤ 10 severe cognitive impairments. The reported score will be corrected according to age and education.
baseline, 8, and 22 weeks later
change in short and medium term memory
Alzheimer's Disease Assessment Scale (ADAS-cog) consists of 11 items that investigate: short and medium term memory, language, praxia (simple, constructive, ideational), temporal-spatial orientation. The score ranges from 0 (no cognitive impairment) to 70 (maximum cognitive impairment).
baseline, 8 and 22 weeks later
Secondary Outcomes (4)
change in quality of life
baseline and 8, 22 weeks later
change in physical performance
baseline, 8 and 22 weeks later
change in signs and symptoms of major depression
baseline, 8 and 22 weeks later
change in neuropsychiatric disturbances
baseline, 8 and 22 weeks later
Study Arms (2)
JDome rehabilitation group
EXPERIMENTALPatients will undergo cognitive training with Brainer web platform via tablet followed by aerobic exercise with the JDome System
control group
ACTIVE COMPARATORPatients will undergo cognitive training with Brainer web platform via tablet followed by aerobic exercise with standard exercise bike
Interventions
Sixteen treatment sessions of 60 minutes will be conducted (2 training sessions per week, for 8 weeks). Each session will involve the following activities: * 30 minutes of computerized cognitive training with the Brainer web platform, a medical device that contains 78 exercises in the five cognitive areas involved in the degeneration process of dementia * 30 minutes of aerobic training with the JDOME system,
Sixteen treatment sessions of 60 minutes will be conducted (2 training sessions per week, for 8 weeks). Each session will involve the following activities: * 30 minutes of computerized cognitive training with the Brainer web platform, a medical device that contains 78 exercises in the five cognitive areas involved in the degeneration process of dementia * 30 minutes of aerobic training with standard exercise bike
Eligibility Criteria
You may qualify if:
- Aged 65 and over;
- Pre-existing diagnosis of Alzheimer's, in mild phase, according to the 2011 criteria of the National Institute on Aging-Alzheimer's Association (NIA-AA);
- Clinical Dementia Rating Scale CDR = 1;
- Mini Mental State Examination MMSE \> 19;
- Functional Ambulation Categories FAC ≥4;
- Tinetti scale ≥ 20;
- Presence of a contact family caregiver
- Reside at home
You may not qualify if:
- Sensory deficits not compensated by the use of prostheses
- Psychological and behavioral disorders not compensated by drug treatment
- Medical contraindication to moderate intensity aerobic exercise
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Cognitive Disorders and Dementia (CDCD) -INRCA Hospital
Ancona, 60127, Italy
Related Publications (1)
Gambella E, Margaritini A, Benadduci M, Rossi L, D'Ascoli P, Riccardi GR, Pasquini S, Civerchia P, Pelliccioni G, Bevilacqua R, Maranesi E. An integrated intervention of computerized cognitive training and physical exercise in virtual reality for people with Alzheimer's disease: The jDome study protocol. Front Neurol. 2022 Aug 12;13:964454. doi: 10.3389/fneur.2022.964454. eCollection 2022.
PMID: 36034306DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Giuseppe Pelliccioni, MD
IRCCS INRCA, Ancona, Italy
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 30, 2022
First Posted
June 2, 2022
Study Start
June 27, 2022
Primary Completion
June 26, 2023
Study Completion
June 26, 2023
Last Updated
October 26, 2023
Record last verified: 2023-10
Data Sharing
- IPD Sharing
- Will not share